Lunchtime Session Sponsored by Accurant Biotech
Lunchtime Session Sponsored by Accurant Biotech
Accurant Biotech is a global CRO, providing regulated bioanalytical, bio-pharmaceutical, and companion diagnostic (CLIA certified) services. The company is focused on PK/ADA/NAb/PD method development, validation, and sample analysis in support of preclinical studies and clinical trials. Our assay platforms include ligand binding, flow-cytometry, IHC/IF, qPCR/dPCR, LC/MS, etc.
Accurant has 3 GLP labs in US (Cranbury NJ) and China (Shanghai, Ningbo), over 200+ staffs and 100,000+ SF lab space. The team has participated in 40+ therapeutic targets, 60+ biologics pipelines, and 120+ clinical trials. In 2021, Accurant successfully supported the approval of Carteyva®, the first category 1 CAR-T product in China.
In this presentation, we will share our experience on biologics, cell and gene therapy bioanalysis service, with some case studies solving tough issues such as drug tolerance and target interference.